Who are the peers of the KMS Medisurgi?
KMS Medisurgi's peers include Aspira Pathlab, Amkay Products, N G Industries, Bandaram Pharma, Deccan Healthcar, Medinova Diagno., Tejnaksh Health., GKB Ophthalmics, and Transgene Biotek. In terms of performance, Aspira Pathlab leads with a 1-year return of 64.58%, while KMS Medisurgi has a return of 0.80%.
Peers: The peers of KMS Medisurgi are Aspira Pathlab, Amkay Products, N G Industries, Bandaram Pharma, Deccan Healthcar, Medinova Diagno., Tejnaksh Health., GKB Ophthalmics, and Transgene Biotek.Quality Snapshot: Excellent management risk is observed at Amkay Products and Shree Pacetronix, while Average management risk is found at KMS Medisurgi, N G Industries, and Bandaram Pharma, and the rest. Below Average management risk is noted at Aspira Pathlab, Deccan Healthcar, Tejnaksh Health., and GKB Ophthalmics, while Medinova Diagno. and Transgene Biotek do not qualify. Growth is Excellent at Bandaram Pharma, Average at KMS Medisurgi and N G Industries, Below Average at Aspira Pathlab, Amkay Products, Deccan Healthcar, Tejnaksh Health., and GKB Ophthalmics, and the rest do not qualify. Capital Structure is Good at KMS Medisurgi, N G Industries, Deccan Healthcar, Tejnaksh Health., and GKB Ophthalmics, Average at Aspira Pathlab and Amkay Products, Below Average at Bandaram Pharma, and the rest do not qualify.
Return Snapshot: The peer with the highest 1-year return is Aspira Pathlab at 64.58%, while the peer with the lowest is Transgene Biotek at -49.45%. KMS Medisurgi's 1-year return is 0.80%, which is significantly lower than Aspira Pathlab's but higher than Transgene Biotek's. Additionally, several peers, including Deccan Healthcar, GKB Ophthalmics, and Shree Pacetronix, have negative six-month returns.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
